ORLANDO – Bicalutamide significantly improved overall survival of men with locally advanced, nonmetastatic prostate cancer, but offered no additiona... More »
Active surveillance may not be the best option for patients diagnosed with intermediate-risk prostate cancer, results of a prospective study suggest.
... More »
PARIS – Health status should be evaluated when determining how best to treat an older man with prostate cancer, attendees at an international congre... More »
PARIS – Health status should be evaluated when determining how best to treat an older man with prostate cancer, attendees at an international congre... More »
Men with favorable intermediate-risk prostate cancer could be considered for active surveillance, say the authors of a study, published in JAMA Oncolo... More »
Adding radiotherapy to androgen-deprivation therapy for locally advanced prostate cancer improves overall survival 30% in the long term, according to ... More »
HYATTSVILLE, MD. – The majority of a Food and Drug Administration advisory panel voted against approval of an orally disintegrating sublingual table... More »
Prevalent oral human papillomavirus 16 infections in men persist longer than newly acquired infections, and the rate of persistence for incident infec... More »
Patients with prostate cancer who have elevated levels of testosterone should be investigated for use of topical androgens taken either by themselves ... More »
Patients with prostate cancer who have elevated levels of testosterone should be investigated for use of topical androgens taken either by themselves ... More »